To validate the pivotal role of RAC1 in tumor development, we performed functional assays using five cell lines representing three cancer types: breast cancer (MDA-MB-231 and BT549), lung adenocarcinoma (A549 and NCI-H1395), and gastric cancer (AGS). This evidence concerns the gene RAC1 and neoplasm.